Press Releases Resonance Health Limited

Equities

Delayed Australian S.E. Other stock markets 11:29:09 28/06/2024 am IST			5-day change	1st Jan Change
0.059 ^AUD	-4.84%		-1.67%	-1.67%

07/06	Resonance Health Receives R&D Tax Rebate of AU$818,706	MT
31/05	Resonance Health Acquires TrialsWest	MT

Resonance Health : Quarterly Activities/Appendix 4C Cash Flow Report	02/22/02	PU
VGI Health Technology Limited (NSX:VTL) Contract with Resonance Health (ASX:RHT)	25/22/25	AQ
Resonance Health : US FDA Clearance for LiverSmart	30/21/30	PU
Resonance Health : Investor Presentation - Positioning for Growth	25/21/25	PU
Resonance Health : THALASSEMIA INTERNATIONAL FEDERATION TO DEPLOY FERRISMART	15/21/15	PU
EASL Digital #NAFLDSummit 2021: Resonance Health presents, HepaFat-AI results equivalent to a conventional MRS technique	24/21/24	PU
Resonance Health : Appointment of GM - Global Sales & Marketing	28/21/28	PU
Resonance Health : News - June 2021	18/21/18	PU
Resonance Health : HepaFat-AI Receives CE Marking	24/21/24	PU
Resonance Health : HepaFat-AI gains US FDA clearance	09/20/09	PU
R&D Update: New Pulmonary Embolism AI Solution Developed	06/20/06	PU
Resonance Health : Files New Provisional Patent	25/20/25	PU
Resonance Health : Partners with Siemens Healthineers	29/19/29	PU
Resonance Health : Investor Presentation November 2019	25/19/25	PU
Resonance Health : New Artificial Intelligence Tool for Automated Assessment of Liver Fat	21/19/21	PU
Resonance Health : News - April 2019	29/19/29	PU
Resonance Health : Response to ASX Price and Volume Query	11/18/11	PU
Resonance Health : FDA Clearance Granted for FerriSmart	03/18/03	PU
Resonance Health : R&D Tax Incentive	20/18/20	PU
Resonance Health : Change of Director's Interest Notice	16/18/16	PU

No results for this search